Immune Regulation News Volume 16.02 | Jan 19 2024

    0
    8








    2024-01-19 | IRN 16.03


    Immune Regulation News by STEMCELL Technologies
    Vol. 16.02 – 19 January, 2024
    TOP STORY

    Autoreactive T Cells Target Peripheral Nerves in Guillain–Barré Syndrome

    Researchers characterized more than 1,000 autoreactive single T cell clones, which revealed a polyclonal T cell receptor repertoire, short CDR3β lengths, preferential HLA-DR restrictions, and recognition of immunodominant epitopes.
    [Nature]

    Full Article
    An informative, visually-compelling wallchart detailing the organization and biology of the respiratory system. Request your copy.
    PUBLICATIONSRanked by the impact factor of the journal

    Bispecific Dendritic-T Cell Engager Potentiates Anti-Tumor Immunity

    Scientists developed a bispecific dendritic cell-T cell engager, a reagent that facilitated physical interactions between PD-1+ T cells and conventional type I dendritic cells.
    [Cell]

    AbstractGraphical Abstract

    Neddylation Is a Novel Therapeutic Target for Lupus by Regulating Double Negative T Cell Homeostasis

    The authors reported that neddylation inactivation with MLN4924, a specific inhibitor of NEDD8-activating enzyme E1, or genetic abrogation of Ube2m in T cells decreased double-negative T cell accumulation and attenuated murine lupus development.
    [Signal Transduction And Targeted Therapy]

    Full Article

    The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn’s Disease

    Investigators overlapped differentially expressed genes with publicly available microarray datasets and performed functional in vitro studies, including an in vitro suppression assay and organoid systems, to model gene expression changes observed in Crohn’s disease Tregs and to test predicted therapeutics.
    [Gastroenterology]

    Abstract

    Neutrophil Extracellular Traps Induced by Chemotherapy Inhibit Tumor Growth In Vivo

    Scientists reported that a combination of glutaminase inhibitor CB-839 and 5-FU inhibited the growth of PIK3CA mutant colorectal cancers in xenograft, syngeneic, and genetically engineered mouse models in part through neutrophil extracellular traps.
    [Journal Of Clinical Investigation]

    AbstractGraphical Abstract

    Mural Cells Interact with Macrophages in the Dura Mater to Regulate CNS Immune Surveillance

    Researchers demonstrated that mural cells decreased coverage around blood vessels in the dura, the outermost layer of the meninges, and upregulated gene pathways involved in leukocyte migration in presymptomatic experimental autoimmune encephalomyelitis.
    [Journal of Experimental Medicine]

    Full Article
    Graphical Abstract

    The Effector Program of Human CD8 T Cells Supports Tissue Remodeling

    Antigen-specific assay systems revealed that human CD8 T cells not only mediated cytotoxicity but also promoted tissue remodeling.
    [Journal Of Experimental Medicine]

    Full Article

    Adipose-Tissue Regulatory T Cells Are a Consortium of Subtypes that Evolves with Age and Diet

    Researchers employed single-cell RNA sequencing, single-cell Tra and Trb sequencing, adoptive transfers, photoconvertible mice, cellular interaction analyses, and in vitro cultures to dissect the evolving heterogeneity of epididymal visceral adipose tissue Tregs with aging and obesity.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    BACH2-Mediated CD28 and CD40LG Axes Contribute to Pathogenesis and Progression of T Cell Lymphoblastic Leukemia

    The authors found extremely low levels of BTB and CNC homology 2 (BACH2) in T-ALL clinical samples and cell lines compared to normal T cells. Overexpression of BACH2 in T-ALL cells not only induced cell growth retardation but also inhibited cancer progression and infiltration in xenografts.
    [Cell Death & Disease]

    Full Article
    Daniel Grey investigates cell death modification as a potential therapy for immune disorders. View his profile.
    REVIEWS

    Efficacy and Safety of JAK Inhibitors in Rheumatoid Arthritis: Update for the Practising Clinician

    The registrational clinical trials and registry data of JAK inhibitors did not identify a difference in the risk of major adverse cardiovascular events, venous thromboembolism, malignancies or infections with a JAK inhibitor versus a biologic DMARD.
    [Nature Reviews Rheumatology]

    Abstract

    The NF-κB Signaling System in the Immunopathogenesis of Inflammatory Bowel Disease

    Investigators summarize their knowledge of the roles of these NF-κB pathways, which are activated in different intestinal cell types by specific ligands, and their cross-talk, in fueling aberrant intestinal inflammation.
    [Science Signaling]

    Abstract
    INDUSTRY AND POLICY NEWS

    US FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Takeda announced that the FDA approved HYQVIA® for the treatment of chronic inflammatory demyelinating polyneuropathy CIDP as maintenance therapy to prevent the relapse of neuromuscular disability and impairment in adults.
    [Takeda]

    Press Release

    Novartis Acquires Calypso Biotech for up to $425 Million

    Calypso Biotech, a European immunotherapy biotech company focused on the research and development of novel biologics, announced it had agreed to be acquired by Novartis. Calypso’s shareholders are set to receive an upfront payment of $250 million and are eligible to receive development milestones of up to $175 million.
    [PharmTech.com]

    Press Release
    FEATURED EVENT

    BioProcess International US West 2024

    March 11 – 14, 2024
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientists – New Immune Checkpoints and Immunotherapies

    Albert Einstein College of Medicine – New York, New York, United States

    Intern – Cell Therapy

    Sanofi – Cambridge, Massachusetts, United States

    Postdoctoral Fellow – Regenerative Medicine

    University of Illinois at Chicago College of Medicine – Chicago, Illinois, United States

    Postdoctoral Fellows – Immunology

    Northwestern University – Chicago, Illinois, United States

    PhD Positions – Tissue Regeneration and Cancer Immunotherapy

    Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2